Therapies

As a science-driven and patient-focused company, Incyte aims to make a difference—for patients, medical professionals, organizations, the broader healthcare community and all of our global stakeholders.

For Patients

Our Commitment to Patients

Our highly experienced team has built a fully integrated U.S. infrastructure with strong coordination across all functions to successfully deliver on our commitment to patients with previously unmet treatment needs.

Image of logo for Jakafi® (ruxolitinib) tablets

Learn more about Jakafi® (ruxolitinib)

Image of logo for Pemazyre® (pemigatinib) tablets - 13.5mg, 9mg, 4.5 mg

Learn more about Pemazyre® (pemigatinib)

Image of logo for MONJUVI® (tafasitamab-cxix) 200mg - for injection, for intravenous use

Learn more about Monjuvi® (tafasitamab-cxix)

 


For Healthcare Professionals

Our Commitment to You and Your Patients

Incyte is committed to helping you positively impact the lives of patients with therapies that fill unmet treatment needs and with programs that remove barriers to access and assist with ongoing support.

Image of logo for Jakafi® (ruxolitinib) tablets

Learn more about Jakafi® (ruxolitinib)

Image of logo for Pemazyre® (pemigatinib) tablets - 13.5mg, 9mg, 4.5 mg

Learn more about Pemazyre® (pemigatinib)

Image of logo for MONJUVI® (tafasitamab-cxix) 200mg - for injection, for intravenous use

Learn more about Monjuvi® (tafasitamab-cxix)

Image of medical information logo call us at 1-855-4med-info (855-463-3463).

Medical Information

Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you are seeking medical information on our products, or wish to meet with a Medical Science Liaison, please visit lncyteMI.com.

To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463).
 

For Healthcare Professionals

Image of logo for Iclusig® (ponatinib)

Incyte is committed to helping you positively impact the lives of patients with therapies that fill unmet treatment needs.

Learn more about Iclusig® (ponatinib)

Image of logo for Pemazyre® (pemigatinib) tablets - 13.5mg, 9mg, 4.5 mg

Learn more about Pemazyre® (pemigatinib)

Image of logo for Minjuvi® (tafasitamab)

Learn more about Minjuvi® (tafasitamab)

Image of Incyte Global Medical Information Logo

Global Medical Information

Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you need medical information or have a medical question, please visit incyteglobalmedicalinformation.com.

To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Global Medical Information.